干细胞治疗市场规模、份额及成长分析（按细胞来源、类型、治疗应用和地区）－2025-2032 年产业预测

全球干细胞治疗市场预计到 2023 年将达到 123 亿美元，从 2024 年的 140.6 亿美元成长到 2032 年的 409.6 亿美元，预测期内（2025-2032 年）的复合年增长率为 14.3%。

受癌症等疾病日益流行的推动以及再生医学的进步，全球干细胞治疗市场正在经历显着增长。干细胞是开发有助于癒合和组织再生的专门细胞的普遍来源，使干细胞疗法成为传统器官移植的可行替代方案。研究人员正在创新性地培养和改造干细胞以产生特定细胞，例如心肌或血细胞，从而扩大治疗选择。此外，源自成体组织的诱导诱导性多功能干细胞的潜力正在支持市场，为治疗带来新的希望。此外，干细胞移植等治疗方法可取代受损细胞，彻底改变血液相关疾病和恶性肿瘤的治疗方式，凸显出巨大的市场潜力。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 专利分析
• 技术分析
• 案例研究

干细胞治疗市场规模：依细胞来源及复合年增长率（2025-2032）

• 市场概览
• 脂肪组织来源的间质干细胞
• 骨髓间质间质干细胞
• 胎盘/脐带来源的间质干细胞
• 其他的

干细胞治疗市场规模（按类型及复合年增长率）（2025-2032）

• 市场概览
• 同种异体干细胞治疗
• 自体干细胞治疗

干细胞治疗市场规模：依治疗应用及复合年增长率（2025-2032）

• 市场概览
• 肌肉骨骼疾病
• 伤口和手术
• 发炎与自体免疫疾病
• 再生医学
• 药物研发
• 心血管疾病
• 神经系统疾病
• 其他的

干细胞治疗市场规模：依地区及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Novartis AG（Switzerland）
• Pfizer Inc.（US）
• Mesoblast Limited（Australia）
• Gamida Cell Ltd.（Israel）
• Vericel Corporation（US）
• Medipost Co., Ltd.（South Korea）
• Astellas Pharma Inc.（Japan）
• Cynata Therapeutics Limited（Australia）
• Lonza Group Ltd.（Switzerland）
• Caladrius Biosciences, Inc.（US）
• Athersys, Inc.（US）
• Cytori Therapeutics, Inc.（US）
• Holostem Terapie Avanzate Srl（Italy）
• Pluristem Therapeutics Inc.（Israel）
• BioTime, Inc.（US）
• Smith+Nephew（UK）
• JCR Pharmaceuticals Co., Ltd.（Japan）
• Anterogen Co., Ltd.（South Korea）
• Corestem, Inc.（South Korea）
• Pharmicell Co., Ltd（South Korea）

结论和建议

Global Stem Cell Therapy Market size was valued at USD 12.3 billion in 2023 and is poised to grow from USD 14.06 billion in 2024 to USD 40.96 billion by 2032, growing at a CAGR of 14.3% during the forecast period (2025-2032).

The global stem cell therapy market is witnessing significant growth, driven by the increasing prevalence of diseases such as cancer and advancements in regenerative medicine. Stem cells serve as a versatile source for developing specialized cells to aid in healing and tissue regeneration, positioning stem cell therapy as a viable alternative to traditional organ transplantation. Researchers are innovatively cultivating and modifying stem cells to create specific cell types, such as heart muscle or blood cells, enhancing treatment options. The market is further supported by the potential of induced pluripotent stem cells derived from adult tissue, promising new avenues in therapy. Additionally, procedures like stem cell transplants, which replace damaged cells, are transforming how blood-related disorders and malignancies are treated, highlighting immense market potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Stem Cell Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Stem Cell Therapy Market Segments Analysis

Global Stem Cell Therapy Market is segmented by Cell Source, Type, Therapeutic Application and region. Based on Cell Source, the market is segmented into Adipose Tissue-derived Mesenchymal Stem Cells, Bone Marrow-derived Mesenchymal Stem Cells, Placenta/Umbilical Cord-derived Mesenchymal Stem Cells and Other. Based on Type, the market is segmented into Allogeneic Stem Cell Therapy and Autologous Stem Cell Therapy. Based on Therapeutic Application, the market is segmented into Musculoskeletal Disorders, Wounds & Surgeries, Inflammatory & Autoimmune Diseases, Regenerative Medicine, Drug Discovery and Development, Cardiovascular Diseases, Neurological Disorders and Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Stem Cell Therapy Market

The Global Stem Cell Therapy market is significantly driven by financial support from government agencies and favorable regulatory frameworks that create a supportive environment for research and development in this field. The growing demand for innovative and effective treatment alternatives for autoimmune, neurological, and cardiovascular disorders has led to heightened research initiatives and increased funding for cell-based studies. This emphasis on advancing therapeutic solutions fosters a robust landscape for stem cell research, ultimately enhancing the potential for breakthroughs and improvements in patient care, thus propelling the expansion of the stem cell therapy market on a global scale.

Restraints in the Global Stem Cell Therapy Market

The global stem cell therapy market faces significant challenges primarily due to ethical concerns surrounding the use of embryonic stem cells. These cells are predominantly sourced from human embryos, raising moral issues related to the potential destruction of human life. This ethical dilemma complicates the commercial development of stem cell treatments. Furthermore, the landscape for stem cell research and applications is inconsistent across different regions, influenced by varying regulations and public perceptions. As a result, these factors create a complex environment that hinders advancements and acceptance within the stem cell therapy market.

Market Trends of the Global Stem Cell Therapy Market

The Global Stem Cell Therapy market is witnessing significant growth and transformation, driven by advancements in therapeutic innovations and increased demand for regenerative medicine. Pharmaceutical companies are actively seeking specialized talent with expertise in stem cell research and product development, reflecting a shift towards more complex therapeutic applications. As they explore novel drug delivery systems and expand their product portfolios, collaboration with firms possessing deep knowledge in biological sciences and controlled release methodologies has become paramount. This trend highlights the burgeoning intersection of research and commercialization in stem cell therapies, paving the way for breakthrough treatments and improved patient outcomes in the healthcare sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Patent Analysis
• Technology Analysis
• Case Studies

Global Stem Cell Therapy Market Size by Cell Source & CAGR (2025-2032)

• Market Overview
• Adipose Tissue-derived Mesenchymal Stem Cells
• Bone Marrow-derived Mesenchymal Stem Cells
• Placenta/Umbilical Cord-derived Mesenchymal Stem Cells
• Other

Global Stem Cell Therapy Market Size by Type & CAGR (2025-2032)

• Market Overview
• Allogeneic Stem Cell Therapy
• Autologous Stem Cell Therapy

Global Stem Cell Therapy Market Size by Therapeutic Application & CAGR (2025-2032)

• Market Overview
• Musculoskeletal Disorders
• Wounds & Surgeries
• Inflammatory & Autoimmune Diseases
• Regenerative Medicine
• Drug Discovery and Development
• Cardiovascular Diseases
• Neurological Disorders
• Other

Global Stem Cell Therapy Market Size & CAGR (2025-2032)

• North America (Cell Source, Type, Therapeutic Application)
  • US
  • Canada
• Europe (Cell Source, Type, Therapeutic Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Cell Source, Type, Therapeutic Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Cell Source, Type, Therapeutic Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Cell Source, Type, Therapeutic Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mesoblast Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gamida Cell Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vericel Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medipost Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Astellas Pharma Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cynata Therapeutics Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caladrius Biosciences, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Athersys, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytori Therapeutics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Holostem Terapie Avanzate S.r.l. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pluristem Therapeutics Inc. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioTime, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith+Nephew (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JCR Pharmaceuticals Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anterogen Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corestem, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharmicell Co., Ltd (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations